pharmaceutical companies

US President Donald Trump holds an executive order about tariffs increase, flanked by US Commerce Secretary Howard Lutnick, in the Oval Office of the White House in Washington, DC, US, February 13, 2025 Photo: Reuters
Global Economy

Big pharma fears best-selling drugs in crosshairs of US-EU tariff spat

In conversations with US officials, the pharmaceutical industry argued that tariffs on the EU would increase drug costs and create access barriers for patients

Infographics: TBS
Stocks

Most top drugmakers diverge from double-digit growth trajectory

Pharmaceuticals back in production, ending worker unrest
Industry

Pharmaceuticals back in production, ending worker unrest

How pharmas performed against high headwinds
Stocks

How pharmas performed against high headwinds

As medicine prices increase, the poorest one-fifth of households will face a difficult tradeoff between life-saving medicines and other basic needs. Photo: Mumit M
Panorama

Pharma industry needs to prepare for headwinds

Pharma companies: A safe haven for investors in this bear market
Thoughts

Pharma companies: A safe haven for investors in this bear market

Top drugmakers keep growth trajectory in H1
Stocks

Top drugmakers keep growth trajectory in H1

Drugmakers find silver lining in pandemic
Economy

Most pharma companies post higher annual profits

Pritha Tiffany Patwary. Illustration: TBS
Thoughts

Are we the lab rats of pharmaceutical companies?

Representational image. Picture: Collected
Stocks

Three pharma companies ordered to repay intercompany loans

Photo:AFP via BSS.
Coronavirus chronicle

Pharma chiefs vow no ‘cut corners’ in vaccine race

The urgent need for effective Covid-19 treatments and vaccines is causing a shift in drugmakers’ priorities. Photographer: Andrey Rudakov/Bloomberg
Panorama

Pharma rivals are fighting Covid together. Why stop there?

Photo: Mumit M/TBS
Trade

‘Bangladesh’s annual pharma export to cross $1bn in 2 years’